Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Public health and hepatitis C.

Patrick DM, Buxton JA, Bigham M, Mathias RG.

Can J Public Health. 2000 Jul-Aug;91 Suppl 1:S18-21, S19-23. Review. English, French.

PMID:
11059125
2.

Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.

Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.

PMID:
17854731
3.

Epidemiology of hepatitis C virus infection in Australia.

Dore GJ, Law M, MacDonald M, Kaldor JM.

J Clin Virol. 2003 Feb;26(2):171-84. Review.

PMID:
12600649
4.

Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.

Xia X, Luo J, Bai J, Yu R.

Public Health. 2008 Oct;122(10):990-1003. doi: 10.1016/j.puhe.2008.01.014. Epub 2008 May 19. Review.

PMID:
18486955
5.

HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention.

Hagan H, Thiede H, Des Jarlais DC.

AIDS. 2005 Oct;19 Suppl 3:S199-207. Review.

PMID:
16251818
6.

Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update.

Smith BD, Jorgensen C, Zibbell JE, Beckett GA.

Clin Infect Dis. 2012 Jul;55 Suppl 1:S49-53. doi: 10.1093/cid/cis363. Review.

PMID:
22715214
7.

Global epidemiology of hepatitis C virus infection.

Shepard CW, Finelli L, Alter MJ.

Lancet Infect Dis. 2005 Sep;5(9):558-67. Review.

PMID:
16122679
8.

HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection.

Hagan H, Des Jarlais DC, Stern R, Lelutiu-Weinberger C, Scheinmann R, Strauss S, Flom PL.

Int J Drug Policy. 2007 Oct;18(5):341-51. Epub 2007 May 2. Review.

PMID:
17854721
9.

Prevention of spread of hepatitis C.

Alter MJ.

Hepatology. 2002 Nov;36(5 Suppl 1):S93-8. Review.

PMID:
12407581
10.

Hepatitis C virus transmission dynamics in injection drug users.

Hagan H.

Subst Use Misuse. 1998 Apr;33(5):1197-212. Review.

PMID:
9596383
11.

HCV routes of transmission: what goes around comes around.

Alter MJ.

Semin Liver Dis. 2011 Nov;31(4):340-6. doi: 10.1055/s-0031-1297923. Epub 2011 Dec 21. Review.

PMID:
22189974
12.

[Prevention of hepatitis C virus infection in drug users].

Schulte B, Stöver H, Leicht A, Schnackenberg K, Reimer J.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Oct;51(10):1210-7. doi: 10.1007/s00103-008-0656-9. Review. German.

PMID:
18985415
13.

Epidemiology of hepatitis C in the Republic of Moldova: achievements and remaining challenges in prevention and control.

Guriev V, Spinu C, Sajen O, Isac M, Spinu I, Cebotari S, Donos A.

J Infect Dev Ctries. 2016 Nov 24;10(11):1162-1167. doi: 10.3855/jidc.7884. Review.

14.

National campaign against hepatitis C in France (1999-2002).

Jullien-Depradeux AM, Bloch J, Le Quellec-Nathan M, Abenhaim A.

Acta Gastroenterol Belg. 2002 Apr-Jun;65(2):112-4. Review.

PMID:
12148431
15.

Current status of hepatitis C in Canada.

Zou S, Tepper M, Giulivi A.

Can J Public Health. 2000 Jul-Aug;91 Suppl 1:S10-5, S10-6. Review. English, French. No abstract available.

PMID:
11059123
16.

Epidemiology of hepatitis C in Europe.

Negro F.

Dig Liver Dis. 2014 Dec 15;46 Suppl 5:S158-64. doi: 10.1016/j.dld.2014.09.023. Epub 2014 Oct 22. Review.

17.

Global control of hepatitis C: where challenge meets opportunity.

Thomas DL.

Nat Med. 2013 Jul;19(7):850-8. doi: 10.1038/nm.3184. Review.

Supplemental Content

Support Center